Haematology 12 - Lymphoma 2 Flashcards

1
Q

How do Reed Sternberg cells appear on the blood film?

A

Giant cell surrounded by reactive eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the age distribution of Hodgkin’s lymphoma?

A

Females 20-29 (typically nodular sclerosing)

M=F, elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the symptoms of Hodgkin’s lymphoma?

A

Painless lymphadenopathy, that becomes painful on drinking alcohol
Constitutional B symptoms
If advanced lymphadenopathy, may –> obstructive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the cause of constitutional B symptoms in lymphoma?

A

Hyper-catabolic state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which investigation is used to diagnose hodgkin’s lymphoma, and which diagnosis is used for staging?

A

Diagnosis: LN biopsy
Staging: FDG-PET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Recall the different stages of Hodgkin’s lymphoma

A

I: one group of nodes
II: >1 group of nodes, on one side of the diaphragm
III: Nodes on both sides of the diaphragm
IV: extranodal spread
Then:
A: no B symptoms
B: one/ any of fever/ weight loss/ night sweats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which subtype of lymphoma is most likely to affect young women?

A

Nodular sclerosing Hodgkin’s

Nodular lymphocyte predominant Hodgkin’s mainly affects the elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What type of chemotherapy is used in Hodgkin’s lymphoma?

A

ABVD
All patients started on chemo even if stage1
This drug regimen preserves fertility

Patients considered for rituximab (anti-cd20) or nivolumab (PD1 inhibitor- increases anti-tumour activity of T cells) if they fail ABVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

After how many cycles of chemotherapy for Hodgkin’s lymphoma should the FDG-PET be repeated to check response?

A

After 2 cycles

And at the end of the treatment (outcomes of this will recommend if radiotherapy is needed or not)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the risk of giving radiotherapy for Hodgkin’s lymphoma?

A

It produces a lot of collateral damage, and when given alongside chemotherapy increases the risk of secondary malignany significantly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Recall 4 prognostic markers in lymphoma

A
  1. LDH
  2. Performance status
  3. HIV serology- increases risk of b-cell lymphomas due to underactive t-cells
  4. Hep B serology-immunotherapy regimens can lead to reactivation of virus and subsequent liver damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How aggressive is diffuse large B cell non-Hodgkin’s lymphoma?

A

High grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How aggressive is follicular non-Hodgkin’s lymphoma?

A

Indolent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is diffuse large B cell non-Hodgkin’s lymphoma treated?

A

R-CHOP
Patients who relapse are considered for autologous stem cell transplantation (25% cure rate)

Aim of treatment is to cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What mutation is commonly associated with follicular non-Hodgkin’s lymphoma?

A

t(14;18)

Translocation of Bcl2 –> oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which subtype of non-Hodgkin’s lymphoma is associated with chronic H. pylori?

A

Extra-nodal marginal zone lymphoma

17
Q

What are the symptoms of extra-nodal marginal zone lymphoma?

A

Epigastric pain, ulceration and bleeding

18
Q

How aggressive is enteropathy-associated non-hodgkin’s lymphoma?

A

Very aggressive

19
Q

What is the main association of enteropathy-associated non-hodgkin’s lymphoma?

A

Coeliac

20
Q

What finding on a blood film is typial of CLL?

A

Smear/ smudge cells

21
Q

Recall the surface markers of intermediate B cells vs mature B cells vs CLL mature B cells

A

Intermediate B cell: CD5 positive
Mature B cell: CD19 positive
Mature CLL B cell: CD5 positive and CD19 positive

22
Q

What are the 2 staging methods that can be used in CLL?

A

Rai staging

Binet staging

23
Q

Is CLL a pre- or post-germinal centre malignancy?

A

50% pre, 50% post

24
Q

How can pre- and post-germinal centre CLL be differentiated?

A

VDJ sequencing

Pre germinal centre-Unmutated VDJ= much worse prognosis

25
Q

Which mutation is associated with a particularly poor prognosis in CLL?

A

17p deletion (TP53)

26
Q

What is Richter’s syndrome?

A

Rare transformation of CLL to high grade lymphoma

27
Q

Recall 3 classes of targeted therapy that can be given to treat CLL

A
  1. BCR kinase inhibitors (eg ibrutinib and idelalisib)- BCR Kinase important in B Cell signalling, blocking this results in B cell depletion
  2. BCL2 inhibitors (eg venetoclax)- promotes apoptosis
  3. CAR-T and other experimental cell-based therapies
28
Q

What type of lymph node biopsy will help you diagnose lymphomas

A

Excision biopsy or core biopsy

Fine needle aspirate is useless- while not tell you anything because wont show you the structure of the lymph node. All the cells will just be smeared on the slide

29
Q

Which of the Classical Hodgkin’s has a poor prognosis?

A

Lymphocyte depleted cHL

30
Q

How to differentiate symptoms of HL and NHL

A

HL will have more contiguous spread with patients often presenting with mediastinal masses. NHL will be more widespread

Both will present with painless lymphadenopathy, B symptoms (except MZL) and compression symptoms, but in HL there might be painful lymph nodes after drinking

31
Q

How is follicular non-Hodgkin’s lymphoma treated?

A

R-COP
Treatment is not curative
Watch and wait recommended first, only treat if clinically indicated (compression symptoms, painful nodes, recurrent infections)

32
Q

Laboratory findings of CLL

A

Lymphocytosis (5-300 x 10^9)
Smear cells
Normocytic normochromic anaemia
Thrombocytopaenia

Cancer of mature b lymphocytes (pre and post germinal follicle)

33
Q

Poor prognostic markers of CLL

A

CD38
pre-GC, IgH unmutated
17p(TP53) deletion